166 related articles for article (PubMed ID: 28920929)
1. Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ.
Di Matteo A; Franceschini M; Paiardini A; Grottesi A; Chiarella S; Rocchio S; Di Natale C; Marasco D; Vitagliano L; Travaglini-Allocatelli C; Federici L
Oncogenesis; 2017 Sep; 6(9):e379. PubMed ID: 28920929
[TBL] [Abstract][Full Text] [Related]
2. N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
De Cola A; Franceschini M; Di Matteo A; Colotti G; Celani R; Clemente E; Ippoliti R; Cimini AM; Dhez AC; Vallée B; Raineri F; Cascone I; Destouches D; De Laurenzi V; Courty J; Federici L
Cancer Lett; 2018 Jan; 412():272-282. PubMed ID: 29111347
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
Federici L; Falini B
Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
5. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin in Its Interaction with Ligands.
Cela I; Di Matteo A; Federici L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract][Full Text] [Related]
11. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
[TBL] [Abstract][Full Text] [Related]
13. Proteomics analysis identifies the ribosome associated coiled-coil domain-containing protein-124 as a novel interaction partner of nucleophosmin-1.
Çakırca G; Öztürk MT; Telkoparan-Akillilar P; Güllülü Ö; Çetinkaya A; Tazebay UH
Biol Cell; 2024 Jan; 116(1):e202300049. PubMed ID: 38029384
[TBL] [Abstract][Full Text] [Related]
14. A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Bolli N; De Marco MF; Martelli MP; Bigerna B; Pucciarini A; Rossi R; Mannucci R; Manes N; Pettirossi V; Pileri SA; Nicoletti I; Falini B
Leukemia; 2009 Mar; 23(3):501-9. PubMed ID: 19005479
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.
López DJ; Rodríguez JA; Bañuelos S
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140532. PubMed ID: 32853771
[TBL] [Abstract][Full Text] [Related]
17. How does the NPM1 mutant induce leukemia?
Sportoletti P
Pediatr Rep; 2011 Jun; 3 Suppl 2(Suppl 2):e6. PubMed ID: 22053282
[TBL] [Abstract][Full Text] [Related]
18. Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter.
Gallo A; Lo Sterzo C; Mori M; Di Matteo A; Bertini I; Banci L; Brunori M; Federici L
J Biol Chem; 2012 Aug; 287(32):26539-48. PubMed ID: 22707729
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.
Di Natale C; La Manna S; Malfitano AM; Di Somma S; Florio D; Scognamiglio PL; Novellino E; Netti PA; Marasco D
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):637-644. PubMed ID: 30710643
[TBL] [Abstract][Full Text] [Related]
20. G-quadruplex DNA recognition by nucleophosmin: new insights from protein dissection.
Scognamiglio PL; Di Natale C; Leone M; Poletto M; Vitagliano L; Tell G; Marasco D
Biochim Biophys Acta; 2014 Jun; 1840(6):2050-9. PubMed ID: 24576674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
